Most Recent
Fitch wins $12M security despite class action’s claims of ‘Rolls-Royce’ defence
A judge has ordered a class action against Fitch to fork over $12.4 million in security, refusing to discount the sum for what the class action called the company's 'Rolls-Royce' defence.
Construction PRO
Test case on cards in dispute between Iplex, BGC over pipes
A class acton against Fletcher Building’s Iplex over thousands of allegedly burst pipes in homes around Australia is gearing up for a mammoth 12-week trial, with a separate claim by BGC, which installed the pipes, to proceed by way of a test case.
Cosette says Mayne backfilled sales estimates to meet $69.8M forecast
Kicking off its appeal of a finding that it couldn't walk away from a $672 million merger agreement with Mayne Pharma, US drug company Cosette has told a court that Mayne was not upfront about its financial position prior to the deal.
BCC, Tokio Marine have mixed success in Greensill privilege spat
Lender White Oak may argue that settlement communications in proceedings over the collapse of supply chain finance company Greensill were in furtherance of fraud and should be turned over, after partially succeeding in a privilege fight with insurers BCC Trade Credit and Tokio Marine.
RAMS franchisee doesn’t want to be ‘swept into’ class action trial
A former RAMS franchisee has raised concerns about a joint trial of its case with a related class action against the defunct Westpac home loan subsidiary, saying the overlap between the cases may be “much less than advertised”.
Construction PRO
Council wins case over minister’s sale of Crown land for subdivision
A court has found that a minister's decision to sell a section of Crown land to a buyer intending to carve it into 15 lots was made in breach of planning laws. 
Top 10 class action settlements of 2025
Class action settlements hit major milestones last year, with the year’s largest settlements totalling $1.6 billion and one case resolving for a historic $548.5 million.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.